Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.42
Delayed Data
As of 4:01pm ET
 -0.08 / -5.33%
Today’s Change
0.75
Today|||52-Week Range
2.50
+6.77%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.50
Today’s open1.49
Day’s range1.42 - 1.51
Volume648,305
Average volume (3 months)486,480
Market cap$233.4M
Dividend yield--
Data as of 4:01pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.15%
P/E ratioNM
Price/Sales15.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CRHMCRH Medical Corp-0.14-4.31%
--China Health Group I...0.000.00%
MNOVMediciNova Inc-0.16-2.29%
PRTKParatek Pharmaceutic...-0.34-2.50%
Data as of 3:59pm ET, 05/03/2016

Financials

Last reporting dateMay 3, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$13.2M
Annual profit (last year)-$27.6M
Net profit margin-213.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
Chief Operating Officer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts

Partner Offers

Search for Jobs